

* Approvals for inhaled drugs from GSK, Novartis, SkyePharma * SkyePharma shares up more than 15 percent (Adds detail on Novartis drug, SkyePharma s...


African Minerals: Investec reduces target price from 393p to 246p, while its buy recommendation remains unchanged. Ashmore Group: Berenberg cuts targ...


* No increased risk seen with Boehringer's Spiriva Respimat * New study contrasts with safety concerns raised in 2011 LONDON, Sept 8 (Reuters) - A maj...


AMEC: Nomura reduces target price from 1300p to 1230p, while reiterating its buy recommendation. Antofagasta: Exane cuts target price from 1200p to 1...